Natural-cause mortality and C-reactive protein levels in patients with schizophrenia spectrum disorders: A prospective total cohort study
Farivar Fathian, Ivana Divkovic, Maria Fagerbakke Strømme, Arnstein Mykletun, Rune A. Kroken, Christoffer A. Bartz-Johannessen, Erik Johnsen
https://doi.org/10.1016/j.bbih.2025.101133
Phenotypic complexities of rare heterozygous neurexin-1 deletions
Michael B Fernando, Yu Fan, Yanchun Zhang, Alex Tokolyi, Aleta N Murphy, Sarah Kammourh, P J Michael Dean , Sadaf Ghorbani, Ryan Onatzevitch, Adriana Pero, Christopher Padilla, Sarah E Williams, Erin K Flaherty, Iya A Prytkov , Lei Cao, David A Knowles , Gang Fang, Paul A Slesinger, Kristen J Brennand
https://www.nature.com/articles/s41586-025-08864-9
Dynamic convergence of neurodevelopmental disorder risk genes across neurodevelopment. bioRxiv. 2025. The publication is accepted and In Press in the Nature Neuroscience journal.
Garcia MF, Retallick-Townsley K, Pruitt A, Davidson E, Balafkan N, Warrell J, Huang TC, Kibowen A, Chu Z, Dai Y, Fitzpatrick SE, Meng R, Sen A, Cohen S, Livoti O, Khan S, Becker C, E Silva ALT, Liu J, Dossou G, Cheung J, Liu S, Ghorbani S, Deans PJM, Ceciucis M, Emani P, Gao H, Shen H, Gerstein M, Wang Z, Huckins LM, Hoffman EJ, Brennand K.
doi: 10.1101/2024.08.23.609190
Prednisolone add-on in early phase schizophrenia: A randomized, double-blind, placebo-controlled pilot study
Gunhhild E Hoprekstad, Erik Johnsen, Christoffer Bartz-Johannessen, Jill Kristin Bjarke, Petros Drosos, Ole Bert Fasmer, Kristian Varden Gjerde, Solveig K Reitan, Silje Skrede, Iris E C Sommer, Lena Stabell, Vidar M Steen, Rune A Kroken
https://doi.org/10.1016/j.bbih.2025.101047
